AZN

Astrazeneca plc

186.65

Oct 30 • 3:59 PM ET +12.25 (7.02%)

185.55

Aftermarket • 7:59 PM ET -1.10 (-0.59%)

Healthcare Drug Manufacturers - General United Kingdom Mega NYSE

Today, 1:30 PMAstraZeneca beats Q3 estimates, outlines 'Reshaping for Sustainable Growth', and terminates Phase III AWAKE trial of Ultomiris

Peers: MRK NVS GSK PFE BMY JNJ ABBV LLY SNY AMGN

| Held by: PVAL AVDE DIHP PBPH DFIC PPH FVD DFAX IDEQ APIE

Scroll to Statements

Index	-
Market Cap	289.48B
Enterprise Value	316.82B
Income	10.45B
Sales	61.37B
Book/sh	32.43
Cash/sh	3.20
Dividend Est.	3.34 (1.79%)
Dividend TTM	3.23 (1.73%)
Dividend Ex-Date	Aug 07, 2026
Dividend Gr. 3/5Y	1.78% 3.25%
Payout	47.19%
Employees	96100
IPO	Oct 17, 2003

P/E	27.90
Forward P/E	16.44
PEG	1.46
P/S	4.72
P/B	5.76
P/C	58.27
P/FCF	26.63
EV/EBITDA	15.77
EV/Sales	5.16
Quick Ratio	0.67
Current Ratio	0.89
Debt/Eq	0.64
LT Debt/Eq	0.52
Option/Short	Yes / Yes

EPS (ttm)	6.69
EPS next Y	11.36
EPS next Q	2.43
EPS this Y	11.95%
EPS next Y	10.74%
EPS next 5Y	11.28%
EPS past 3/5Y	45.90% 22.05%
Sales past 3/5Y	9.82% 16.31%
EPS Y/Y TTM	25.90%
Sales Y/Y TTM	8.61%
EPS Q/Q	2.26%
Sales Q/Q	6.41%
Earnings	Oct 30 BMO
EPS/Sales Surpr.	7.91% 1.30%

Insider Own	3.44%
Insider Trans	-0.02%
Inst Own	60.86%
Inst Trans	-1.00%
ROA	9.15%
ROE	21.99%
ROIC	13.69%
Gross Margin	73.93%
Oper. Margin	22.38%
Profit Margin	17.02%
SMA20	12.46%
SMA50	13.48%
SMA200	3.67%
Trades

Shs Outstand	1.55B
Shs Float	1.50B
Short Float	0.22%
Short Ratio	0.97
Short Interest	3.28M
52W High	212.71 -12.25%
52W Low	153.41 21.66%
Volatility	1.81% 1.87%
ATR (14)	4.44
RSI (14)	75.14
Beta	0.32
Rel Volume	1.61
Avg Volume	3.39M
Volume	5,465,719

Perf Week	8.84%
Perf Month	18.36%
Perf Quarter	18.16%
Perf Half Y	1.03%
Perf YTD	6.35%
Perf Year	14.04%
Perf 3Y	50.55%
Perf 5Y	48.99%
Perf 10Y	229.48%
Recom	1.55
Target Price	223.15
Prev Close	174.40
Price	186.65
Change %	7.02%

Consensus

Buy

Avg. Price Target

$223.15

Implied Upside

+19.6%

Analysts3incl. previous ratings

Rating Distribution1 Buy · 2 Hold · 0 Sell

Date	Action	Analyst	Rating Change
Sep 15, 2026	Upgrade	DDeutsche Bank	Sell → Hold
Sep 09, 2026	Initiated	RRBC Capital Mkts	Outperform
Jul 13, 2026	Downgrade	HHSBC Securities	Buy → Hold

Today 03:46PM	COVID Vaccine Giant AstraZeneca Stock Jumps 7%. What's Behind It? (BeInCrypto) +7.02%
01:26PM	AstraZeneca cans late-stage Ultomiris trial on lacklustre efficacy predictions (Clinical Trials Arena)
10:55AM	Drugs giant AstraZeneca reveals higher profits, savings plan (AFP)
09:44AM	Pre-Markets Spooked on Questions Regarding AI, Oil Prices (Zacks)
08:43AM	AstraZeneca Has an $80 Billion Dream and a Plan to Fix Its Stalling Stock (Barrons.com)
08:41AM	Loading…
08:41AM	AstraZeneca profit jumps 23% on cancer drugs as it unveils major savings plan (Euronews)
08:04AM	AstraZeneca is launching a $1.5 billion cost-savings program to fund its drug pipeline (Quartz)
07:38AM	AstraZeneca CEO Sees Over $20B Potential From 2027 Drug Trial Readouts AZN Stock Eyes Breakout After Q3 Earnings Beat (Stocktwits)
07:16AM	MARKETS LIVE: Nasdaq futures tumble as AI spending fears hit Wall Street (Proactive)
05:30AM	AstraZeneca rises 4% as Jefferies and UBS assess profit beat (Proactive)
03:52AM	AstraZeneca Q3 Profit Rises; Reconfirms FY26 Revenue, Core EPS Guidance At CER (RTT News)
03:40AM	AstraZeneca shares gain after Q3 profit beats forecasts, outlook unchanged (Investing.com)
03:37AM	Astrazeneca: Q3 Earnings Snapshot (Associated Press)
03:30AM	AstraZeneca holds guidance as cancer drugs outrun the Farxiga generics hit (Proactive)
Oct-28-26 08:00AM	AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing (Business Wire)
01:57PM	Loading…
Oct-27-26 01:57PM	AstraZeneca may start work on cancer vaccines, CEO says (Investing.com)
01:20PM	AstraZeneca might develop cancer vaccines, CEO tells analysts at oncology conference (Quartz)
10:30AM	AstraZeneca offers compelling risk-reward into 2027 pipeline readouts, says JPMorgan (Proactive)
Oct-26-26 10:52AM	Moderna's Cancer Vaccine Rally Hits a Wall. This Other Drugmaker Stole the Show. (Barrons.com)
08:36AM	ESMO26: Key data breathing new life into the lung cancer field (Clinical Trials Arena)
08:00AM	AstraZeneca is readying its own cancer-targeting drug for regulatory approval after trial win (Quartz)
06:39AM	Pathos AI completes $237m Series E round to expand oncology pipeline (Hospital Management)
Oct-23-26 04:09AM	U.S. Treasury Wants to Rein In Deals for Chinese Biotech and AI (Barrons.com)
Oct-22-26 10:21AM	AstraZeneca Launches Targeted Lung Cancer Drug In US After FDA Accelerated Approval (Stocktwits)
09:33AM	AstraZeneca bags another US indication for Ultomiris with IgAN approval (Pharmaceutical Technology)
07:32AM	AstraZeneca Faces Post-Farxiga Test As Oncology Must Carry Growth After Wynua Miss (Earnings Whispers)
Oct-21-26 10:23AM	Arcus kidney cancer data impresses analysts; TriGemX inks a SPAC deal (BioPharma Dive)
06:43AM	Amgen and AstraZeneca report Phase III Tezspire data for EoE (Clinical Trials Arena)
05:40AM	AstraZeneca and Oracle collaborate to test AI in clinical trial recruitment (Clinical Trials Arena)
Oct-20-26 09:00AM	Jefferies puts AstraZeneca kidney drug trial success odds at 59% (Proactive)
07:03AM	Loading…
07:03AM	Oracle, AstraZeneca Explore AI To Tackle Clinical-Trial Recruitment Challenge (Stocktwits)
06:41AM	AstraZeneca and Oracle Launch AI Partnership to Improve Clinical Trials and Patient Care (InvestorsHub)
06:28AM	Why AZN, VSXY, EYPT Stocks Are Moving Premarket Today (Stocktwits)
03:00AM	Ambrose Healthcare fortifies rare disease pipeline on AM-Pharma takeover (Pharmaceutical Technology)
Oct-19-26 10:03AM	Real-time clinical trials: what it means for procurement strategy (Clinical Trials Arena)
07:56AM	Britain govt held talks With UBS over potential London move report (Private Banker International)
Oct-16-26 07:57PM	Stocktwits Biotech Dealmaker: Gilead, AstraZeneca And Roche Chase Pipeline Expansion Over Buyouts (Stocktwits)
07:24AM	AstraZeneca and insitro forge $1.5bn AI-powered cardiometabolic partnership (Pharmaceutical Technology)
07:13AM	UK stocks set for weekly gains as investors seek shelter in defensive sectors (Reuters)
Oct-15-26 12:25PM	UK's FTSE 100 closes at seven-week high on fiscal reassurance, defensive buying (Reuters)
10:30AM	RBC keeps AstraZeneca at outperform ahead of AVANZAR lung cancer trial (Proactive)
08:18AM	AstraZeneca, insitro Strike AI Drug Discovery What Investors Need To Know (Stocktwits)
07:32AM	AstraZeneca Signs AI Drug-Discovery Deal Worth Up to $1.5 Billion. Only $40 Million Is Guaranteed (TIKR)
Oct-14-26 04:28PM	Top Research Reports for Mastercard, AstraZeneca & Sandisk (Zacks)
12:31PM	UK stocks close higher as weaker sterling boosts export-heavy sectors (Reuters)
11:13AM	Tech stocks take a back seat as healthcare names steal the show (MarketWatch)
Oct-12-26 11:02AM	AstraZeneca's efzimfotase alfa adult data point to $4.4bn peak sales potential, says Citi (Proactive)
08:09AM	Bausch + Lomb swaps CEOs; Merck reveals anticipated eye drug data (BioPharma Dive)
07:42AM	AstraZeneca pins bone disease drugs Phase III failure on high placebo response (Clinical Trials Arena)
Oct-11-26 09:22PM	SLS Stock Jumps Overnight: Retail Sees Big Pharma Buyout Clues In 'M&A Negotiation Lounge' Booth At ASH (Stocktwits)
Oct-10-26 09:19AM	Flu season is already here. Here's what to know about this year's flu shots. (MarketWatch)
Oct-08-26 09:00AM	SOPHiA GENETICS and Myriad Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology (PR Newswire)
09:00AM	Pharmas $500B patent problem will come in waves not as a cliff (Pharma Voice)
Oct-07-26 09:09AM	Micro-Cap Stock Veraxa Biotech Is Down 96% This Year. Can Next-Gen Drug Testing Save It? (Barrons.com)
07:00AM	Jefferies maintains 'buy' rating on AstraZeneca ahead of third-quarter results (Proactive)
Oct-06-26 10:01PM	Goldman Sachs Says China Biotech Is Where Big Pharma Is Shopping Now (BeInCrypto)
09:00AM	Citi raises AstraZeneca target to £186 as tozorakimab prospects improve (Proactive)
07:44AM	AstraZeneca CEO Pascal Soriot on Summit ivonescimab combos (Quartz)
06:41AM	AstraZeneca opens new R&D centre in Cambridge, US (Pharmaceutical Business Review)
Oct-05-26 04:30PM	AstraZeneca CEO says Summit drug could drive next generation of cancer combinations (CNBC TV)
01:52PM	AstraZeneca opens $1 billion R&D center in Massachusetts (Quartz)
12:01PM	AstraZeneca opens new global strategic R&D center in Kendall Square, Cambridge, Massachusetts (Business Wire)
09:36AM	Will there be more to Daiichis story than DXd ADCs? (Pharma Voice)
07:00AM	AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics (Business Wire)
Oct-02-26 08:13PM	Stocktwits Biotech Dealmaker Novartis, Sanofi And Novo Sign Weeks Biggest Deals (Stocktwits)
01:58PM	AstraZeneca Stocks Moves Lower as Datroway Combination Enters Phase 3 (GuruFocus.com)
10:30AM	AstraZeneca deepens Summit ties on ADC-bispecific cancer combo testing pact (Pharmaceutical Technology)
08:38AM	Summit Teams Up With Daiichi Sankyo, AstraZeneca For Cancer Therapy Trial CEO Calls It An Important Expansion (Stocktwits)
Oct-01-26 07:57PM	AstraZeneca Stocks Drops as $2 Billion Buys an Oncology Option (GuruFocus.com)
Sep-30-26 10:32AM	Adding Lilly's new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects. (MarketWatch)
Sep-29-26 01:17PM	AstraZeneca Stock Slips as $2 Billion Summit Stake Deepens Oncology (GuruFocus.com)
12:07PM	Summit Stock Jumps 17% on $2 Billion AstraZeneca Investment (GuruFocus.com)
08:49AM	AstraZeneca invests $2B in Summit, gaining seat at the table for PD-1/VEGF drug push (BioPharma Dive)
08:30AM	AstraZenecas $2 billion Summit stake wins backing from UBS and Jefferies (Proactive)
07:39AM	Premarket movers: FICO sinks while Summit, AAR and CarMax rise (Investing.com)
06:34AM	AstraZeneca to invest $2bn in Summit for ADC combination therapies (Pharmaceutical Technology)
06:24AM	Summit Therapeutics Shares Rise 22% After $2 Billion AstraZeneca Investment (InvestorsHub)
02:32AM	AstraZeneca invests $2 billion in Summit Therapeutics in cancer drug deal (Proactive)
Sep-28-26 07:35PM	SMMT Stock Soars After-Hours: Did AstraZeneca Just End Summits Cash Scare? (Stocktwits)
06:08PM	Summit shares surge after-hours on $2 billion AstraZeneca equity deal (Investing.com)
05:30PM	AstraZeneca Makes $2 Billion Strategic Equity Investment in Summit Therapeutics (Business Wire)
08:50AM	What Bavarian Nordics next CEO is up against (Pharma Voice)
Sep-25-26 08:00AM	Nuvectis' In-Licensed Cancer Drug Earned Breakthrough Designation in China, and It's Not Even Their Lead Asset (FinanceWire)
Sep-23-26 10:52AM	European big pharma unites amid ringing alarm bells of continents dominance (Clinical Trials Arena)
08:41AM	Novo Nordisk Stock Slides After Unveiling Long Term Pipeline Growth Targets (TIKR)
05:55AM	Biotech is one area where the US can afford to let China flourish (Financial Times)
12:00AM	Ozempic-maker Novo open to upgrading US listing (Financial Times)
Sep-22-26 03:26PM	AstraZeneca and GSK warn Europes drug industry is at risk (The Telegraph)
Sep-21-26 11:55AM	Novo Nordisk shares plunge over 7% as new targets fail to reassure investors (Proactive)
08:20AM	Novo Nordisk Stock Drops 5.6% as 2030 Goals Match Peers (GuruFocus.com)
Sep-17-26 03:16PM	AstraZeneca Gains as Enhertu Clears England's Value Gate (GuruFocus.com)
01:00AM	The West is hooked on Chinese drugs but they could save your life (The Telegraph)
Sep-16-26 03:03PM	AstraZeneca Shares Rise as J.P. Morgan Stays Overweight (GuruFocus.com)
10:37AM	AstraZeneca shares oversold after trial flops and merger talk, says UBS (Proactive)
07:05AM	AstraZeneca's news flow next year could sustain drugs group beyond 2030, says leading bank (Proactive)
Sep-15-26 08:02AM	WCLC 26: A new ADC era, China questions and AstraZenecas spotlight (BioPharma Dive)
07:11AM	CLLS Stock Heads For 14-Month Low After 40% Rout: Citizens Flags Delayed Cellectis Catalysts After Cancer Pipeline Pivot (Stocktwits)
Sep-14-26 12:46PM	AstraZenecas cancer pipeline posts two wins and a loss (Clinical Trials Arena)
08:30AM	AstraZenecas newly approved pill fails frontline breast cancer study (BioPharma Dive)
08:10AM	Olema Pharmaceuticals Shares Fall 15.1% Following AstraZeneca SERENA-4 Trial Results (InvestorsHub)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sharma Mani	See Remarks	Aug 08 '26	Buy	160.57	20	3,249	19,288	Sep 11 04:05 PM
Sharma Mani	See Remarks	May 20 '26	Sale	185.78	11,893	2,209,482	19,262	May 22 04:05 PM

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

M.B.A.Mr. Pascal Claude Roland Soriot D.V.M.

CFO & Executive DirectorDr. Aradhana Sarin M.D.

EVP of Global opt. & ITMs. Pam P. Cheng

Head of Investor RelationsMr. Joris Silon

CHROMr. Jeffrey Pott J.D.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

AZN

Astrazeneca plc

Upgrade your Finviz experience